Michael Adornetto, DO
Michael Adornetto, DO, is board certified in internal medicine and pediatrics. He received his bachelor’s degree from Bowling Green State University and his doctorate degree at Ohio University College of Osteopathic Medicine. He completed his internship at Brentwood Hospital and his dual residency training in internal medicine and pediatrics at the Cleveland Clinic Foundation. Dr. Adornetto is one of the founding associates of Westshore Primary Care Associates and has co-directed the Internal Medicine Program at University Hospitals St. John Medical Center since 2001. In 2007, he was appointed as the President of Westshore Primary Care.
- Chronic Disease Management
- Family Medicine
- Internal Medicine
- Preventive Care
Patient Satisfaction Reviews
4.9 out of 5
Patient Comments (8)
Reviewed On 5/1/2020
this was a virtual visit. the doctor did everything possible to help me
Reviewed On 3/21/2020
He has always been a great doctor.
Reviewed On 11/30/2019
All experience was very good.
Reviewed On 10/20/2019
Reviewed On 10/15/2019
I like my Dr and want to stick with him. He seems thorough.
Reviewed On 10/8/2019
the doctor was very attentive to my questions and my health with good bedside manners
Reviewed On 10/4/2019
the wait time was almost an hour do to the fact that the medical assistant had to ask everyone their history as the records did not transfer [...].
Reviewed On 8/31/2019
excellent listener, truly caring
- Internal Medicine - American Osteopathic Board of Internal Medicine
Residency | Internal Medicine/Pediatrics
Internal Medicine/Pediatrics - Cleveland Clinic (1990 - 1994)
Internship | Rotator
Rotator - Brentwood Hospital (1989 - 1990)
Ohio University College Of Osteopathic Medicine (1989)
Bowling Green State University (1984)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Michael Adornetto did not disclose any Outside Relationships with Industry.